Trial Profile
An open-label, randomized, 3-way crossover study to evaluate the relative bioavailability of a single oral dose of naproxen 500 mg administered as PN 400 (naproxen / esomeprazole), as the [active comparator 1], or as [active comparator 2] in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2010
Price :
$35
*
At a glance
- Drugs Esomeprazole/naproxen (Primary) ; Naproxen
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- Sponsors POZEN
- 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2008 New trial record.